Table 1 Clinical characteristics and ECMO outcomes for critically ill COVID-19 patients (N = 12)
Variables | Mean (SD) | Range | n | % |
|---|---|---|---|---|
Age (years) | 50.9 (13.5) | 35–76 |  |  |
Gender (male) | Â | Â | 11 | 91.7 |
Comorbidities | ||||
 Hypertension |  |  | 1 | 8.3 |
 Heart disease |  |  | 1 | 8.3 |
 Diabetes |  |  | 1 | 8.3 |
 Hyperthyroidism |  |  | 1 | 8.3 |
Key reason for ICU admittance | ||||
 Dyspnea |  |  | 11 | 91.7 |
 Fever |  |  | 10 | 83.3 |
 Coma |  |  | 1 | 8.3 |
Treatment type | ||||
 ECMO |  |  | 12 | 100 |
 Mechanical ventilation |  |  | 12 | 100 |
 Antibiotic treatment |  |  | 12 | 100 |
 Antiviral therapy |  |  | 12 | 100 |
 Glucocorticoid therapy |  |  | 10 | 83.3 |
 Supportive therapy based on symptoms |  |  | 12 | 100 |
Duration of ECMO use (days) | 11.3 (7.8) | 3–28 |  |  |
ECMO prognosis | ||||
 Improving without ECMO |  |  | 3 | 25.0 |
 Still alive with ECMO but two with coma |  |  | 4 | 33.3 |
 Dying |  |  | 5 | 41.7 |